Detalles de la búsqueda
1.
How to integrate CD19 specific chimeric antigen receptor T cells with other CD19 targeting agents in diffuse large B-cell lymphoma?
Hematol Oncol
; 42(1): e3237, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37937474
2.
[Multiple myeloma in the elderlyâ : impact of a geriatric assessment]. / Le myélome multiple chez la personne âgéeâ : impact d'une évaluation gériatrique.
Rev Med Suisse
; 15(670): 2032-2038, 2019 Nov 06.
Artículo
en Francés
| MEDLINE | ID: mdl-31696678
3.
Remission of relapsed/refractory classical Hodgkin lymphoma induced by brentuximab vedotin and pembrolizumab combination after allogeneic hematopoietic stem cell transplantation: a case report.
Front Immunol
; 15: 1360275, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38510239
4.
Low Plasma Levels of Hyaluronic Acid Might Rule Out Sinusoidal Obstruction Syndrome after Hematopoietic Stem Cell Transplantation.
Dis Markers
; 2023: 7589017, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37101837
5.
Defibrotide Shows Efficacy in the Prevention of Sinusoidal Obstruction Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study.
Transplant Cell Ther
; 28(11): 765.e1-765.e9, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35953029
6.
Evaluation of Disease Risk Comorbidity Index after Allogeneic Stem Cell Transplantation in a Cohort with Patients Undergoing Transplantation with In Vitro Partially T Cell Depleted Grafts.
Transplant Cell Ther
; 27(1): 67.e1-67.e7, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32980547
7.
The EBMT Cytogenetic Risk Score maintains its prognostic significance in acute myeloid leukemia following allogeneic stem cell transplantation in a cohort with 40% of patients transplanted with in vitro partial T-cell depleted graft.
Bone Marrow Transplant
; 56(9): 2284-2286, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34007052
Resultados
1 -
7
de 7
1
Próxima >
>>